Current Neurology and Neuroscience Reports

Psychogenic movement disorders: A crisis for neurology

Mark Hallett

Web alert

Tetrabenazine versus placebo for chorea in huntington’s disease

John C. Morgan, Kapil D. Sethi

Ropinirole versus placebo in primary restless legs syndrome

John C. Morgan, Kapil D. Sethi

Update on huntington’s disease

Sarah B. Berman, J. Timothy Greenamyre

PARK8 LRRK2 parkinsonism

Kristoffer Haugarvoll, Zbigniew K. Wszolek

Preclinical diagnosis of parkinson’s disease: Are we there yet?

Andrew Siderowf, Matthew B. Stern

Impulse control disorders in parkinson’s disease

Daniel Weintraub, Marc N. Potenza

Autoantibodies: A novel etiology for refractory epilepsy?

Carl W. Bazil, Lawrence J. Hirsch

Antiepileptic therapy in patients with central nervous system malignancies

Glen H. J. Stevens

Cognitive functioning following epilepsy surgery

Marla J. Hamberger, Evan B. Drake

Magnetoencephalography in epilepsy: tailoring interpretation and making inferences

Joshua Cappell, Catherine Schevon, Ronald G. Emerson

State of the ketogenic diet(s) in epilepsy

Jennifer Huffman, Eric H. Kossoff

Antiepileptic drugs and neurodevelopment

Gholam K. Motamedi, Kimford J. Meador

Use of complementary and alternative medicine in epilepsy

Valeria Ricotti, Norman Delanty